Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Distraction Cards Versus Emotion-Regulation Toy Squeezing During Intramuscular Vaccination in Preschool Children

torstai 25. kesäkuuta 2026 päivittänyt: Guzide UGUCU, Mersin University

The Effect of Using Distraction Card and Squeezing Emotion-Regulation Toy on Pain and Pain-Related Fear During Intramuscular Vaccination in Children Aged 4-7 Years: A Single-Center, Parallel-Group, Randomized Experimental Study

This single-center, parallel-group, randomized experimental study will compare the effects of two active non-pharmacological interventions - distraction-card use and emotion-regulation toy squeezing - on procedural pain and pain-related fear during intramuscular tetanus vaccination in children aged 4-7 years. Eligible children will be randomized to either the distraction-card group or the emotion-regulation toy-squeezing group. Pain will be assessed using the Wong-Baker FACES Pain Rating Scale, and pain-related fear will be assessed using the Children's Fear Scale before, during, and after the intramuscular injection procedure.

Hypotheses

  • H1a: There is a difference between the groups in mean Wong-Baker FACES scores during the procedure.
  • H1b: There is a difference between the groups in mean Children's Fear Scale scores during the procedure.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

The study is planned as a single-center, randomized experimental trial with two parallel active intervention groups. The study population will consist of children aged 4-7 years for whom intramuscular tetanus vaccination is planned at Mersin University Hospital.

The sample size was calculated using a priori power analysis based on an effect size of d = 0.714 from Ugucu et al. (2022), with alpha = 0.05 and power = 0.80. The final sample is planned as 68 children, with 34 children in each intervention group.

The Pediatric Vaccination/Injection Unit will be arranged to provide the same environmental conditions for all children and parents, including lighting, temperature, noise level, seating, and procedural workflow. It is decorated with cartoon characters and ornaments. Only one child will undergo the procedure in the room at a time. Routine practice will support parental presence during the invasive procedure. The nurse who performs the intramuscular tetanus vaccination will be the same for both groups and children where feasible and will have pediatric clinical experience.

Before the procedure, children will receive an explanation appropriate to their developmental level, and their physical comfort will be ensured. In the distraction-card group, the child will begin using age-appropriate distraction cards two minutes before the intramuscular injection. The child will be actively engaged with the cards through visual attention and simple developmentally appropriate prompts until the injection procedure is completed. In the emotion-regulation toy-squeezing group, the child will begin squeezing an age-appropriate emotion-regulation toy two minutes before the intramuscular injection and will continue until the procedure is completed.

Pain and pain-related fear scores will be recorded by the researchers two minutes before the procedure, during the procedure at needle insertion/vaccine administration, and one minute after the procedure. Data will be collected during the routinely planned intramuscular tetanus vaccination procedure without delaying or replacing standard clinical care.

Data Collection Instruments The Child Information Form, developed after a literature review, will include variables such as the child's age, sex, previous hospitalization and injection/vaccination experience, previous invasive procedure experience, and the presence and frequency of invasive procedure experience in the last week and in the last month.

The Wong-Baker FACES Pain Rating Scale is a valid and reliable measurement tool used to assess acute pain in children older than three years who can communicate. A score of 0 means no pain, and a score of 10 means unbearable/severe pain. According to scoring, 0-4 indicates mild pain, 5-6 moderate pain, 7-8 severe pain, and 9-10 unbearable pain. The approximate administration time is two minutes. Permission to use the scale should be documented before data collection if required.

The Children's Fear Scale assesses pain-related fear in children. The scale consists of five drawn facial expressions scored from 0 to 4, ranging from a neutral expression (0 = no anxiety/fear) to a fearful face (4 = severe anxiety/fear). Scores of 2 and above are commonly interpreted as high fear in the source methodology. The approximate administration time is two minutes. Permission to use the scale should be documented before data collection if required.

Statistical Analysis Plan Data will be analyzed using a statistical package program. The level of statistical significance will be set at 0.05. The Kolmogorov-Smirnov test will be used to assess the normality of dependent variables. Chi-square tests and tests comparing means will be used to determine group similarity. Appropriate parametric or non-parametric tests will be used to compare between-group and within-group means depending on whether the distribution is normal. If differences are found between group means, an effect size appropriate to the test family will be used.

Randomization and Allocation Concealment Block randomization will be used to preserve balance in participant numbers between groups. The randomization list will be generated by an independent statistician using simple random selection through randomizer.org or equivalent computer-assisted randomization. After block randomization, sequential numbers will be placed in closed opaque envelopes to conceal allocation.

Ethics, Consent, and Assent The study will begin after obtaining ethics committee approval from the Mersin University Health Sciences Research Ethics Committee, written institutional permission from the relevant hospital/unit, written informed consent from parents/legal representatives, and verbal assent from children when developmentally appropriate.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

68

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

    • Province
      • Mersin, Province, Turkki (Türkiye), 33343
        • Rekrytointi
        • Mersin University Hospital
        • Ottaa yhteyttä:

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

  • Lapsi

Hyväksyy terveitä vapaaehtoisia

Ei

Kuvaus

Inclusion Criteria:

  • Child aged 4-7 years
  • Child with need or plan for intramuscular vaccination

Exclusion Criteria:

  • Child with a neurodegenerative disease, mental retardation, vision and hearing problems, chronic, life-threatening (sepsis, shock, respiratory / cardiac arrest) or genetic disease
  • Child with use of opioids, narcotics, analgesics or sedatives in the last 24 hours before the procedure

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Tukevaa hoitoa
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Kaksinkertainen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Active Comparator: Distraction-Card Group
Arm type: Experimental. Behavioral intervention: active distraction-card use. Two minutes before the intramuscular tetanus vaccination begins, the child will start using age-appropriate distraction cards. The child will be actively engaged with the cards through visual attention and simple prompts until the injection procedure is completed.
Age-appropriate visual distraction cards suitable for children aged 3-6 years will be used. Cards should be cleanable or single-use according to infection-control practice and should include developmentally appropriate visual content that can maintain the child's attention during the procedure. Two minutes before the intramuscular tetanus vaccination begins, the child will start using age-appropriate distraction cards. The child will be actively engaged with the cards through visual attention and simple prompts until the injection procedure is completed.
Kokeellinen: Emotion-Regulation Toy-Squeezing Group
Arm type: Experimental. Behavioral intervention: active emotion-regulation toy squeezing. Two minutes before the intramuscular tetanus vaccination begins, the child will start squeezing an age-appropriate emotion-regulation toy. The toy-squeezing intervention will continue until the injection procedure is completed.
A safe, age-appropriate, cleanable, medium-firm squeezable emotion-regulation toy appropriate for children aged 3-6 years will be used. The toy should be resistant to tearing and damage and suitable for infection-control procedures between participants if reusable. Two minutes before the intramuscular tetanus vaccination begins, the child will start squeezing an age-appropriate emotion-regulation toy. The toy-squeezing intervention will continue until the injection procedure is completed.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Procedural pain score during intramuscular vaccination
Aikaikkuna: during the procedure at needle insertion/vaccine administration
Procedural pain score during intramuscular tetanus vaccination, assessed using the Wong-Baker FACES Pain Rating Scale. The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst/unbearable pain. Higher scores indicate greater pain.
during the procedure at needle insertion/vaccine administration
Pain-related fear score during intramuscular vaccination
Aikaikkuna: during the procedure at needle insertion/vaccine administration
Pain-related fear score during intramuscular tetanus vaccination, assessed using the Children's Fear Scale. The scale ranges from 0 to 4, from a neutral/no-fear face to a very fearful face. Higher scores indicate greater fear.
during the procedure at needle insertion/vaccine administration

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Pre-procedure pain score
Aikaikkuna: two minutes before intramuscular vaccination
Pre-procedure pain score assessed using the Wong-Baker FACES Pain Rating Scale. The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst/unbearable pain. Higher scores indicate greater pain.
two minutes before intramuscular vaccination
Pre-procedure pain-related fear score
Aikaikkuna: two minutes before intramuscular vaccination
Pre-procedure pain-related fear score assessed using the Children's Fear Scale. The scale ranges from 0 to 4, from a neutral/no-fear face to a very fearful face. Higher scores indicate greater fear.
two minutes before intramuscular vaccination

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Päätutkija: Guzide UGUCU, RN, MScN, PhD, Mersin University

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Sunnuntai 21. kesäkuuta 2026

Ensisijainen valmistuminen (Arvioitu)

Tiistai 15. syyskuuta 2026

Opintojen valmistuminen (Arvioitu)

Perjantai 20. marraskuuta 2026

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Sunnuntai 21. kesäkuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Sunnuntai 21. kesäkuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Torstai 25. kesäkuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Maanantai 29. kesäkuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Torstai 25. kesäkuuta 2026

Viimeksi vahvistettu

Maanantai 1. kesäkuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

IPD-suunnitelman kuvaus

There is not a plan to make IPD available.

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa